Top Ranked Growth Stocks to Buy for March 19th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, March 19th:
Cirrus Logic, Inc. (CRUS): This semiconductor company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13% over the last 60 days.
Cirrus Logic, Inc. Price and Consensus
Cirrus Logic, Inc. price-consensus-chart | Cirrus Logic, Inc. Quote
Cirrus Logic has a PEG ratio of 0.86, compared with 3.30 for the industry. The company possesses a Growth Score of A.
Cirrus Logic, Inc. PEG Ratio (TTM)
Cirrus Logic, Inc. peg-ratio-ttm | Cirrus Logic, Inc. Quote
Mellanox Technologies, Ltd. (MLNX): This fabless semiconductor company, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.
Mellanox Technologies, Ltd. Price and Consensus
Mellanox Technologies, Ltd. price-consensus-chart | Mellanox Technologies, Ltd. Quote
Mellanox has a PEG ratio of 0.75, compared with 3.30 for the industry. The company possesses a Growth Score of A.
Mellanox Technologies, Ltd. PEG Ratio (TTM)
Mellanox Technologies, Ltd. peg-ratio-ttm | Mellanox Technologies, Ltd. Quote
TRI Pointe Group, Inc. (TPH): This company that engages in the design, construction and sale of single-family detached and attached homes carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.8% over the last 60 days.
TRI Pointe Group, Inc. Price and Consensus
TRI Pointe Group, Inc. price-consensus-chart | TRI Pointe Group, Inc. Quote
TRI Pointe has a PEG ratio of 0.36, compared with 0.57 for the industry. The company possesses a Growth Score of A.
TRI Pointe Group, Inc. PEG Ratio (TTM)
TRI Pointe Group, Inc. peg-ratio-ttm | TRI Pointe Group, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
TRI Pointe Group, Inc. (TPH) : Free Stock Analysis Report
Mellanox Technologies, Ltd. (MLNX) : Free Stock Analysis Report
Cirrus Logic, Inc. (CRUS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research